Stockreport

GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators

GRI Bio, Inc.  (GRI) 
PDF Company is strategically building a global patent estate in key territories for a growing pipeline targeting potentially high-value indications in need of innovation [Read more]